sb 203580 has been researched along with sildenafil citrate in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | sb 203580 (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Aguirre, N; Barros-Miñones, L; Goñi-Allo, B; Hervías, I; Orejana, L; Puerta, E; Suquía, V | 1 |
2 other study(ies) available for sb 203580 and sildenafil citrate
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.
Topics: Administration, Oral; Animals; Anthracenes; Apoptosis; Hypoxia, Brain; Imidazoles; Male; Malonates; MAP Kinase Signaling System; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Sildenafil Citrate; Sulfonamides | 2013 |